4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-007027
President and CEO sold 18,334 shares at an average $68.44 ($1,254,819)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-02-01 | Sale | −14,222 | $68.21 | $970,111 | 2,308,761 | I: show line 1 in the form |
| Watts Ryan J. President and CEO | 2021-02-01 | Sale | −3,552 | $69.17 | $245,681 | 2,305,209 | I: show line 2 in the form |
| Watts Ryan J. President and CEO | 2021-02-01 | Sale | −560 | $69.69 | $39,026 | 2,304,649 | I: show line 3 in the form |
| Open-market sales · 18,334 sh · avg $68.44 · $1,254,819 | |||||||
Loading xslF345X03/doc4.xml…